Catalog Number 47286578 |
Device Problem
Leak/Splash (1354)
|
Patient Problem
Underdose (2542)
|
Event Date 05/15/2019 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.The manufacturing location for this product is (b)(4).This site is an oem manufacturing site.Therefore, bd corporate headquarters in (b)(4) has been listed and the (b)(4) fda registration number has been used for the manufacture report number.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
|
|
Event Description
|
It was reported that pen ii omnitrope pen 10 leaked.The following information was provided by the initial reporter: dripping pen.Mother of patient called in to report that the new pen she received from omni source is leaking.She stated having the same issue as last time with it leaking and not sure if her child it getting enough medication.With the leaking pen she said they are running short on medication.Stated it is dripping drops, not a steady stream.
|
|
Event Description
|
It was reported that pen ii omnitrope pen 10 leaked.The following information was provided by the initial reporter: dripping pen.Mother of patient called in to report that the new pen she received from omni source is leaking.She stated having the same issue as last time with it leaking and not sure if her child it getting enough medication.With the leaking pen she said they are running short on medication.Stated it is dripping drops, not a steady stream.
|
|
Manufacturer Narrative
|
Investigation summary: one (1) sample was provided to bd medical ¿ pharmaceutical system (bdm-ps) for analysis.Bdm-ps performed a batch history record¿s review (bhr) including a review of all data collected during in process and quality inspections.The batch involved in this complaint meets all acceptable quality levels (aql¿s), was manufactured and released according to applicable procedures and specifications.Initial evaluation of the returned complaint sample revealed no visible damage to the pen.An injection sequence was executed using a 31g x 5mm bd pen needle and placebo cartridge.The pen was evaluated for leaking from the needle by observing the number of droplets that formed 30 seconds after needle attachment and after administering low dose, mid dose, and high dose injections.For each injection, the 30 second allowance began after a 5 second hold time at the end of injection.Investigator observed droplets forming at the needle tip during the 30 second allowance.The number of droplets observed was as follows: after needle attachment after low dose after mid dose after high dose droplets observed (pen 1) 8 2 1 3 based on investigation conclusion, bdm-ps was able to confirm the detection and characterize the condition reported by customer.The reported condition has been confirmed but is not defined in the applicable specification.As a consequence, bdm-ps will not conduct a full root cause analysis.However this complaint is registered in bd complaint system and trend analysis will be performed.
|
|
Search Alerts/Recalls
|